Emergent BioSolutions (NYSE: EBS) is a specialty biopharmaceutical and contract development and manufacturing company focused on public health threats, including chemical, biological, radiological, and nuclear threats, as well as infectious diseases. The filing excerpts provided do not contain sufficient detail to characterize specific revenue streams, segment breakdowns, product revenue figures, customer concentration, geographic mix, or competitive positioning. All such fields have been left empty or omitted in accordance with source-grounding rules. Only information directly supported by the provided filing excerpts has been included in this description.

Source: SEC 10-K, filed 2026-02-27

Industry: Pharmaceutical Preparations Peers: Vericel Corp Arcutis Biotherapeutics Inc Avidity Biosciences, Inc. Crinetics Pharmaceuticals Inc Enanta Pharmaceuticals Inc ImmunoGen, Inc. Madrigal Pharmaceuticals Inc Morphic Holding, Inc. Sana Biotechnology Inc